Showing session: reset
Regulatory Considerations for Utilizing Liquid Biopsies in Drug and Diagnostic Development
- Sort by:
- Browse by:
- Free
- audio + slides
- Some slides withheld
Invited Speaker
Dana Wai Yi Tsui
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
James H Godsey
Thermo Fisher Scientific, South San Francisco, CA, United States
- Free
- audio + slides
- Some slides withheld
Invited Speaker
J. Carl Barrett
AstraZeneca, Waltham, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Soma Ghosh
U.S. Food and Drug Administration, Silver Spring, MD, United States
- Free
- audio only
- Audio only
Panel Discussion
Gideon Blumenthal
U.S. Food and Drug Administration, Silver Spring, MD, United States
Reena Philip
U.S. Food and Drug Administration, Silver Spring, MD, United States
Dana Wai Yi Tsui
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
James H Godsey
Thermo Fisher Scientific, South San Francisco, CA, United States
J. Carl Barrett
AstraZeneca, Waltham, MA, United States
Soma Ghosh
U.S. Food and Drug Administration, Silver Spring, MD, United States